BOING BOING
The cost of lomustine, a veteran cancer drug, have skyrocketed after a startup bought the rights to it and hiked prices 1,400 percent.
According to the Wall Street Journal, lomustine was sold by Bristol-Myers Squib for years under the brand name CeeNU at a price of about $50 a capsule for the highest dose. The drugmaker sold lomustine in 2013 to a little-known Miami startup called NextSource, which proceeded to hike lomustine's price nine times since. It now charges about $768 per pill for the medication.
According to an analysis done for the Journal by Truveen Health Analytics and Elsevier, NextSource this year raised prices for the drug, which it rebranded as Gleostine, by 12 percent in November following a 20 percent increase in August.
Read more
https://boingboing.net/2017/12/27/price-of-40-year-old-cancer-dr.html
This blog will focus on political images I have found all around the Internet, though I will intersperse some commentary and quotes that I find interesting.
No comments:
Post a Comment